Vaxxas' Series A Round

Vaxxas raised a round of funding on August 02, 2011.

Vaxxas is a privately-held biotechnology company focused on enhancing the performance of existing and next-generation vaccines with its Nanopatch technology platform. Vaxxas' Nanopatch contains an ult…

Articles about Vaxxas' Series A Round: